局部止痛藥的全球市場規模、佔有率和成長分析：按類型、治療層級和分銷管道 - 行業預測（2024-2031）

2022年，全球局部止痛藥市場規模將為104.6億美元，從2023年的111億美元擴大到2031年的178.8億美元，在預測期內（2024-2031年）預計年複合成長率為6.14%。

導致局部鎮痛治療市場收益增加的主要因素之一是關節炎盛行率的上升。老年人口的成長和運動員對這些物品的強勁需求進一步推動了市場擴張。本報告對全球局部疼痛緩解市場進行了全面評估，包括對關鍵細分市場、趨勢、促進因素、限制因素、競爭格局以及影響市場動態的關鍵因素的深入研究。與糖尿病神經病變、關節炎和相關骨骼疾病以及癌症相關的疼痛盛行率不斷上升，是全球局部止痛藥市場快速成長的主要因素。此外，擴大使用局部鎮痛藥，其副作用比口服藥物更少，也是市場擴張的動力。全球老化加劇和運動員對局部疼痛管理的需求不斷成長是推動市場擴張的進一步因素。然而，也存在限制市場成長的因素，例如外用止痛藥可能會刺激皮膚和產生難聞的氣味。同時，局部鎮痛業務擁有誘人的成長機會，包括局部治療線上平台的出現以及新興國家開拓的潛力。這些因素共同影響著市場的軌跡，並突顯了在不斷變化的環境中的機會和挑戰。

目錄

執行摘要

• 市場概況
• 轉型

調查方法

• 資訊採購
• 二級/一級資訊來源
• 市場規模估算
• 市場假設與限制

母市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題

主要市場考察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• Start-Ups分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 總體經濟指標
• 主要投資分析
• 關鍵成功因素
• 競爭程度

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題
• 監管形勢
• 波特的分析
• 對未來顛覆的特別見解

全球局部止痛藥市場：依類型

• 市場概況
• 處方箋止痛藥
• 非處方（OTC）止痛藥

全球局部止痛藥市場：依治療層級

• 市場概況
• 非鴉片類藥物
• 非類固醇消炎劑（NSAIDS）
• 水楊酸甲酯
• 辣椒素
• Lidocaine
• 其他非鴉片類藥物
• 鴉片類藥物
• Buprenornhine
• Fentanyl

全球局部鎮痛藥市場：依分銷管道分類

• 市場概況
• 藥局
• 電子商務
• 零售店/雜貨店

局部鎮痛藥的全球市場規模：依地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲

競爭形勢

• 前5名企業對比
• 主要企業市場定位（2021年）
• 主要市場參與者所採取的策略
• 關鍵成功策略
• 近期市集活動
• 主要企業市場佔有率（2021年）

主要企業簡介

• Johnson & Johnson-USA
• GlaxoSmithKline plc-United Kingdom
• Novartis AG-Switzerland
• Pfizer Inc.-USA
• Reckitt Benckiser Group plc-United Kingdom
• Sun Pharmaceutical Industries Ltd.-India
• Endo International plc-Ireland
• Teva Pharmaceutical Industries Ltd.-Israel
• Sanofi SA-France
• Mylan NV（now part of Viatris Inc.）-USA

Global Topical Pain Relief Market size was valued at USD 10.46 billion in 2022 and is poised to grow from USD 11.10 billion in 2023 to USD 17.88 billion by 2031, growing at a CAGR of 6.14% during the forecast period (2024-2031).

One of the main factors contributing to the increased market revenue of topical pain relief treatments is the rise in the prevalence of arthritis. Further supporting market expansion are the growing geriatric population and the strong demand for these items among athletes. The report provides a thorough evaluation of the global topical pain relief market, including a thorough examination of key market segments, trends, drivers, constraints, the competitive environment, and critical factors influencing market dynamics. The increasing prevalence of diabetes neuropathy, arthritis and related bone disorders, and pain related to cancer are the main drivers of the topical pain relief market's enormous rise on a worldwide scale. The increasing use of topical painkillers, which often cause fewer negative effects than oral counterparts, is another motivating driver. The world's aging population boom and athletes' growing demand for topical pain management are two further factors driving market expansion. However, some factors, such as the possibility of skin irritation from topical painkillers and their unpleasant odour, limit the market's ability to grow. On the other hand, the topical pain relief business has attractive growth opportunities due to the emergence of online platforms for topical therapies and their unrealized potential in emerging nations. Together, these elements influence the market's trajectory, highlighting opportunities as well as problems in this ever-changing environment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segmental Analysis

The therapeutic class, type, distribution channel, formulation, and region are the factors used to segment the global market for topical pain relief. Therapeutic classes include methyl salicylate, capsaicin, lidocaine, non-opioids, opioids, buprenorphine, fentanyl, and nonsteroidal anti-inflammatory drugs (NSAIDS). The market is divided into two categories based on type: over-the-counter and prescription pain relief. The market is divided into four segments based on the distribution channel: retail, drugstore, pharmacy, and grocery store. The market is divided into cream, gel, spray, patch, and other formulation categories. The market is divided into North America, Europe, Latin America, Asia-Pacific, the Middle East, and Africa based on geographic regions.

Drivers of the Global Topical Pain Relief Market

One of the main factors driving the topical pain relief market is the rising prevalence of chronic pain problems such neuropathic pain, arthritis, and musculoskeletal illnesses. Customers are looking for convenient, focused pain relief options that are localized.

Restraints in the Global Topical Pain Relief Market

Even though topical pain relievers are widely used, more substantial clinical research is required to confirm their safety and effectiveness, which will affect consumer acceptance and confidence.

Market Trends of the Global Topical Pain Relief Market

The market is seeing a change in topical pain management solutions toward those with natural and herbal ingredients. Customers are looking for goods that are seen to be healthier and have few synthetic ingredients.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Topical Pain Relief Market by Type

• Market Overview
• Prescription Pain Relief
• Over-the-counter (OTC) Pain Relief

Global Topical Pain Relief Market by Therapeutic Class

• Market Overview
• Non-opioids
• Nonsteroidal anti-inflammatory drug (NSAIDS)
• Methyl Salicylate
• Capsaicin
• Lidocaine
• Other Non-opioids
• Opioids
• Buprenorphine
• Fentanyl

Global Topical Pain Relief Market by Distribution Channel

• Market Overview
• Pharmacy & Drug Store
• e-Commerce
• Retail & Grocery Store

Global Topical Pain Relief Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Johnson & Johnson - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc - United Kingdom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc - United Kingdom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. - Israel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (now part of Viatris Inc.) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments